Yitong Guo

556 total citations
19 papers, 427 citations indexed

About

Yitong Guo is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Yitong Guo has authored 19 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Yitong Guo's work include Liver Disease Diagnosis and Treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver physiology and pathology (3 papers). Yitong Guo is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver physiology and pathology (3 papers). Yitong Guo collaborates with scholars based in China and United States. Yitong Guo's co-authors include Haiping Hao, Guangji Wang, Hong Wang, Shuang Cui, Chaoliang Ge, Ningning Huang, Frank J. Gonzalez, Pengfei Zhang, Li Gu and Wenjing Fu and has published in prestigious journals such as Nature Communications, Journal of Virology and Journal of Leukocyte Biology.

In The Last Decade

Yitong Guo

17 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yitong Guo China 10 187 136 133 119 52 19 427
Manon Homan Netherlands 4 166 0.9× 131 1.0× 166 1.2× 130 1.1× 104 2.0× 5 423
Martina Bordoni Italy 11 122 0.7× 152 1.1× 102 0.8× 64 0.5× 79 1.5× 31 351
Rosalinda Roselli Italy 12 138 0.7× 169 1.2× 105 0.8× 75 0.6× 96 1.8× 26 361
Yasunori Nio Japan 12 175 0.9× 46 0.3× 156 1.2× 121 1.0× 36 0.7× 21 448
Michaela Mueller Austria 6 310 1.7× 160 1.2× 148 1.1× 110 0.9× 139 2.7× 9 507
Amy M. Bataille United States 8 134 0.7× 84 0.6× 161 1.2× 54 0.5× 35 0.7× 10 396
Junli Zhang China 8 165 0.9× 40 0.3× 132 1.0× 43 0.4× 30 0.6× 19 348
Peixin Lu China 8 201 1.1× 122 0.9× 172 1.3× 169 1.4× 20 0.4× 17 585
Dominik Koch Germany 11 138 0.7× 91 0.7× 138 1.0× 91 0.8× 66 1.3× 32 432
Cristina Di Giorgio Italy 16 206 1.1× 286 2.1× 221 1.7× 133 1.1× 154 3.0× 36 648

Countries citing papers authored by Yitong Guo

Since Specialization
Citations

This map shows the geographic impact of Yitong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yitong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yitong Guo more than expected).

Fields of papers citing papers by Yitong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yitong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yitong Guo. The network helps show where Yitong Guo may publish in the future.

Co-authorship network of co-authors of Yitong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yitong Guo. A scholar is included among the top collaborators of Yitong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yitong Guo. Yitong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Li, Junyao, Yu Wang, Yitong Guo, et al.. (2025). A novel method for detecting intracranial pressure changes by monitoring cerebral perfusion via electrical impedance tomography. Fluids and Barriers of the CNS. 22(1). 10–10.
3.
Zheng, Shaoqin, Yitong Guo, Xueqiang Peng, et al.. (2024). STING agonists and PI3Kγ inhibitor co-loaded ferric ion-punicalagin networks for comprehensive cancer therapy. International Journal of Biological Macromolecules. 282(Pt 2). 136776–136776. 3 indexed citations
4.
Guo, Yitong, et al.. (2024). Association of advanced lung cancer inflammation index with all-cause and cardiovascular mortality in US patients with rheumatoid arthritis. Frontiers in Nutrition. 11. 1397326–1397326. 9 indexed citations
5.
Tian, Mei, Yitong Guo, Qing Xia, et al.. (2024). MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential. Genes & Diseases. 12(4). 101287–101287. 3 indexed citations
6.
Xie, Hongkai, Rui Peng, Qixuan Li, et al.. (2023). Genetic Variations in Angiotensinogen Gene and Risk of Preeclampsia: A Pilot Study. Journal of Clinical Medicine. 12(4). 1509–1509. 3 indexed citations
7.
Peng, Rui, Dunjin Chen, Hongkai Xie, et al.. (2023). Associations between IGFBP1 gene polymorphisms and the risk of preeclampsia and fetal growth restriction. Hypertension Research. 46(9). 2070–2084. 4 indexed citations
9.
Song, Jiangwei, Yitong Guo, Dan Wang, et al.. (2023). Seneca Valley virus 3C protease cleaves OPTN (optineurin) to Impair selective autophagy and type I interferon signaling. Autophagy. 20(3). 614–628. 20 indexed citations
10.
Song, Jiangwei, Yitong Guo, Dan Wang, et al.. (2023). Seneca Valley virus 3C pro antagonizes type I interferon response by targeting STAT1-STAT2-IRF9 and KPNA1 signals. Journal of Virology. 97(10). e0072723–e0072723. 10 indexed citations
11.
Lian, Dawei, Li Zhu, Xiaojuan Zhang, et al.. (2022). Kakonein restores hyperglycemia-induced macrophage digestion dysfunction through regulation of cathepsin B-dependent NLRP3 inflammasome activation. Journal of Leukocyte Biology. 112(1). 143–155. 6 indexed citations
12.
Cui, Shuang, Chaoliang Ge, Yitong Guo, et al.. (2021). Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. Chinese Journal of Natural Medicines. 19(6). 401–411. 19 indexed citations
13.
Li, Wenxuan, et al.. (2021). Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis. BMC Complementary Medicine and Therapies. 21(1). 242–242. 23 indexed citations
14.
Xia, Jing, et al.. (2021). Gut Microbiota Mediates the Preventive Effects of Dietary Capsaicin Against Depression-Like Behavior Induced by Lipopolysaccharide in Mice. Frontiers in Cellular and Infection Microbiology. 11. 627608–627608. 44 indexed citations
15.
Cui, Shuang, Yitong Guo, Pengfei Zhang, et al.. (2020). SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nature Communications. 11(1). 240–240. 122 indexed citations
16.
Huang, Ningning, Yitong Guo, Shuang Cui, et al.. (2018). Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis. Acta Pharmaceutica Sinica B. 9(3). 526–536. 77 indexed citations
17.
Wang, Hong, Chaoliang Ge, Yitong Guo, et al.. (2018). Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis. EBioMedicine. 37. 322–333. 45 indexed citations
18.
Wang, Hong, Haiping Hao, Yitong Guo, et al.. (2017). A novel intestinal-restricted FXR agonist. Bioorganic & Medicinal Chemistry Letters. 27(15). 3386–3390. 24 indexed citations
19.
Li, Ying, Shengjie Sun, Qiong Sun, et al.. (2016). High HER-2 protein levels correlate with clinicopathological features in colorectal cancer. Journal of Cancer Research and Therapeutics. 12(1). 323–323. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026